Edmund Waller
Professor of Medicine, Medical Oncology and Pathology
Rein Saral Professor of Cancer Medicine
Interim Associate Director, Clinical Research, Winship Cancer Institute
Medical Director, Center for Stem Cell Processing and Apheresis
Director, Emory Regenerative Engineering and Medicine Center
Dr. Waller specializes in bone marrow transplants for acute leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, lymphoma, aplastic anemia, sickle cell disease and in the management of graft-versus-host disease.
404-778-2984
Office Location:
Winship Cancer Institute of Emory University
University, College, and School/Department
Additional Research:
Dr. Waller's research focus is in enhancing immune reconstitution after stem cell transplant and developing cell and small-molecule based cancer immunotherapeutics. His current research activities include pre-clinical and clinical studies focused on the role of donor immune cells in optimizing anti-tumor immunity after allogenic transplantation, enhancing functional properties of chimeric-antigen-receptor T cells, and blocking novel immune check-point pathways in cancer. His NIH-funded basic and translational research lab uses mouse models and performs immunological analyses of clinical samples from patients. He has active translational research activities and serves as a principal investigator on institutional and national cooperative group clinical trials.
Dr. Waller's research focus is in enhancing immune reconstitution after stem cell transplant and developing cell and small-molecule based cancer immunotherapeutics. His current research activities include pre-clinical and clinical studies focused on the role of donor immune cells in optimizing anti-tumor immunity after allogenic transplantation, enhancing functional properties of chimeric-antigen-receptor T cells, and blocking novel immune check-point pathways in cancer. His NIH-funded basic and translational research lab uses mouse models and performs immunological analyses of clinical samples from patients. He has active translational research activities and serves as a principal investigator on institutional and national cooperative group clinical trials.
IRI Connections:
IRI And Role
